Showing results (411-420 of 451) with videos related to
Sort By:
Pageof 46
Drug Delivery|June 13, 2018
Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategyYuqian Du, Chutong Tian, Menglin Wang, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 21, 2025
Long-acting bioengineered platelets with internal doxorubicin loaded and external quercetin liposomes anchored for post-surgical tumor therapyQi Lu, Zeyu Han, Xia Wang, et al.Molecular Pharmaceutics|February 2, 2011
Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokineticsZhongtian Yan, Jin Sun, Yannan Chang, et al.Acta Pharmaceutica Sinica. B|July 14, 2025
Self-degradable "gemini-like" ionizable lipid-mediated delivery of siRNA for subcellular-specific gene therapy of hepatic diseasesQiu Wang, Bin Wan, Yao Feng, et al.Nanoscale Horizons|March 29, 2020
Light-triggered dual-modality drug release of self-assembled prodrug-nanoparticles for synergistic photodynamic and hypoxia-activated therapyDongyang Zhao, Wenhui Tao, Songhao Li, et al.Journal of Medicinal Chemistry|February 25, 2017
Combination of l-Carnitine with Lipophilic Linkage-Donating Gemcitabine Derivatives as Intestinal Novel Organic Cation Transporter 2-Targeting Oral ProdrugsGang Wang, Hongxiang Chen, Dongyang Zhao, et al.Biomaterials|August 1, 2020
An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibitionKaiyuan Wang, Hao Ye, Xuanbo Zhang, et al.Nature Communications|August 2, 2025
Chimeric exosomes-derived immunomodulator restoring lymph nodes microenvironment for sensitizing TNBC immunotherapyMengchi Sun, Yuxia Wu, Zhichao Chen, et al.Small (Weinheim an Der Bergstrasse, Germany)|July 7, 2025
A "Glue" Strategy to Engineer Cancer Cell Membrane-Camouflaged Prodrug Nanoassemblies for Efficient Targeted ChemotherapyLingxiao Li, Xin Wang, Yafan Xiao, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 1, 2023
Small EV-based delivery of CpG ODNs for melanoma postsurgical immunotherapyYutong Lu, Hao Ye, Jian Zhao, et al.Pageof 46